28
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Expression of FLK1 and CD146 at day 7 following reperfused acute myocardial infarction

, , , , , & show all
Pages 304-307 | Received 19 Mar 2009, Accepted 24 Jun 2010, Published online: 24 Aug 2010

References

  • Tille JC, Wang X, Lipson KE, McMahon G, Ferrara N, Zhu Z, . Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro. Exp Cell Res. 2003;285:286–98.
  • Band M, Shams I, Joel A, Avivi A. Cloning and in vivo expression of vascular endothelial growth factor receptor 2 (Flk1) in the naturally hypoxia-tolerant subterranean mole rat. FASEB J. 2008;22:105–12.
  • Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, . Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res. 2004;64: 8643–50.
  • Zheng C, Qiu Y, Zeng Q, Zhang Y, Lu D, Yang D, . Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization. Int J Biochem Cell Biol. 2009;41:2163–72.
  • Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation. 2000;102:898–901.
  • Jacques N, Vimond N, Conforti R, Griscelli F, Lecluse Y, Laplanche A, . Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay. J Immunol Methods. 2008;337:132–43.
  • Kang S, Yang YJ, Wang QZ, Li Y, Tian Y, Cheng YT. Expressions of eNOS3 and Ve-cadherin in microvascular endothelium at 7-day of reperfused acute myocardial infarction. Cardiovasc Hematol Disord Drug Targets. 2009;9:107–17.
  • Kang S, Yang YJ, Wu YL, Chen YT, Li L, Tian Y. Myocardium and microvessel endothelium apoptosis at day 7 following reperfused acute myocardial infarction. Microvasc Res. 2010;79:70–9.
  • Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29:577–80.
  • Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27–31.
  • Gu X, Cheng L, Chueng WL, Yao X, Liu H, Qi G, . Neovascularization of ischemic myocardium by newly isolated tannins prevents cardiomyocyte apoptosis and improves cardiac function. Mol Med. 2006;12:275–83.
  • Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, . Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med. 1999;5:1135–42.
  • Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–95.
  • Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol. 1996;270:H1803–11.
  • Melnikova VO, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 2006;19:395–405.
  • Ren G, Michael LH, Entman ML, Frangogiannis NG. Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem. 2002; 50:71–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.